Login to Your Account



Pfizer Begins Phase III Studies With Coley's NSCLC Therapy

By Randall Osborne


Tuesday, November 29, 2005
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription